Cardiovascular Systems Top Insiders

Cardiovascular Systems Management Team Effectiveness

The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities. Cardiovascular Systems holds a total of 42.2 Million outstanding shares. The majority of Cardiovascular Systems outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cardiovascular Systems to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cardiovascular Systems. Please pay attention to any change in the institutional holdings of Cardiovascular Systems as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Cardiovascular Systems in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Cardiovascular Systems, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Cardiovascular Systems Workforce Comparison

The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16.

Cardiovascular Systems Insider Trading

Cardiovascular Systems Notable Stakeholders

String symbol = request.getParameter("s");

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.